ACE Report Cover
ESWT vs. HILT in Treating Calcaneal Spur Related Symptoms: Clinical and Functional Outcomes
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
FOOT & ANKLE
ESWT vs. HILT in Treating Calcaneal Spur Related Symptoms: Clinical and Functional Outcomes .

Comparison of extracorporeal shock wave therapy and high-intensity laser therapy in the treatment of calcaneal spur-related symptoms: clinical outcomes and functional improvement.

J Orthop Surg Res . 2025 Apr 19;20(1):393.
Contributing Authors

Z Karakuzu Güngör

Ninety patients with calcaneal spur-related symptoms were randomized to receive either Extracorporeal Shock Wave Therapy (ESWT) (n=45) or High-Intensity Laser Therapy (HILT) (n=45). The primary outcome was pain intensity (Visual Analog Scale [VAS]) and functional outcomes (Foot Function Index [FFI]). Secondary outcomes included range of motion (ROM), Roles and Maudsley scores, and AOFAS scores. Outcomes were assessed at baseline, post-treatment, and three months. Overall, the study revealed significant improvements in pain and functional scores in both groups, with ESWT demonstrating slightly superior improvements in functional outcomes compared to HILT. The main findings suggest that both ESWT and HILT are effective non-invasive treatments for calcaneal spur, with ESWT showing marginally better functional outcomes.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. ESWT vs. HILT in Treating Calcaneal Spur Related Symptoms: Clinical and Functional Outcomes. ACE Report. 2025;307(6):13. Available from: https://myorthoevidence.com/AceReport/Show/eswt-vs-hilt-in-treating-calcaneal-spur-related-symptoms-clinical-and-functional-outcomes

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report